Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

234.56
+4.061.76%
Post-market: 234.560.00000.00%18:18 EDT
Volume:601.35K
Turnover:140.34M
Market Cap:30.37B
PE:-107.64
High:235.12
Open:230.48
Low:228.96
Close:230.50
Loading ...

Barclays Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
26 Feb

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day

Business Wire
·
25 Feb

Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now

Insider Monkey
·
25 Feb

Alnylam Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
25 Feb

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $500 From $400

THOMSON REUTERS
·
24 Feb

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag

Zacks
·
18 Feb

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

Zacks
·
14 Feb

Morgan Stanley Reaffirms Their Hold Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
14 Feb

RBC Raises Price Target on Alnylam Pharmaceuticals to $310 From $300, Keeps Outperform Rating

MT Newswires Live
·
14 Feb

Alnylam Pharma (ALNY) Gets a Buy from Barclays

TIPRANKS
·
14 Feb

Alnylam Pharmaceuticals Price Target Maintained With a $320.00/Share by Needham

Dow Jones
·
14 Feb

Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
14 Feb

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
14 Feb

U.S. RESEARCH ROUNDUP-Airbnb, CVS Health, Roku

Reuters
·
14 Feb

Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
14 Feb

Alnylam Pharmaceuticals Inc : Scotiabank Cuts Target Price to $300 From $310

THOMSON REUTERS
·
14 Feb

Alnylam Pharmaceuticals Reports Strong 2024 Growth

TIPRANKS
·
14 Feb

Alnylam Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
·
13 Feb

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates

Zacks
·
13 Feb